Class II · Moderate risk
Doxazosin 2 mg tablets
cGMP Deviations
National Drug Code
Is NDC 70518-1560-01 recalled?
Doxazosin · 90 TABLET in 1 BOTTLE, PLASTIC (70518-1560-1)
Yes — this exact package was recalled
1 FDA recall names the code 70518-1560-01 directly. A recall still applies to particular lot numbers — compare the lot on your package with the FDA notice below, and talk to your pharmacist before stopping a prescribed medication.
- Active ingredient
- Doxazosin
- Strength
- DOXAZOSIN MESYLATE 2 mg/1
- Form
- Tablet · Oral
- Labeler
- Remedyrepack INC.
- Type
- Human Prescription Drug
- Product code
- 70518-1560
Recalls naming this package
Class II · Moderate risk
Losartan Potassium/HCTZ
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level of 0.96 parts per million.
Where to find this code. The NDC is printed on the pharmacy label and on the manufacturer's carton, usually as three groups of digits after “NDC”. The last group is the package size — two bottles of the same medicine can differ only in that group, and a recall may cover one but not the other.
Other recalled products from this labeler
- 70518-1220 See recall 2
- 70518-3519 See recall 2
- 70518-3772 Clindamycin Hydrochloride 2
- 70518-0060 See recall 1
- 70518-0064 See recall 1
- 70518-0218 Phenazopyridine Hydrochloride 1
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.